Mr Daniel Ayoubkhani
Health Economics & Outcomes Research Ltd, Cardiff (United Kingdom of Great Britain & Northern Ireland)
The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure – Epidemiology, prognosis, outcome
ESC 365 is supported by
